Medications

Skyrizi approved for psoriatic arthritis

(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.

Diseases, Conditions, Syndromes

Expert discusses 'flurona' and why flu cases are rising

Flu cases are starting to rise across parts of the U.S. And that's concerning because fewer people are vaccinated for flu, compared to last year, according to the Centers for Disease Control and Prevention (CDC).

page 1 from 12